Britain’s love affair with sausage rolls and steak bakes is being quietly reshaped by the rise of weight loss injections, according to the boss of Greggs. Roisin Currie, chief executive of the FTSE-listed bakery chain, said there was “no doubt” that appetite-suppressing drugs such as GLP-1